Akero Therapeutics - 53 Year Dividend History | AKRO

Historical dividend payout and yield for Akero Therapeutics (AKRO) since 1971. The current TTM dividend payout for Akero Therapeutics (AKRO) as of May 22, 2024 is $0.00. The current dividend yield for Akero Therapeutics as of May 22, 2024 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.400B $0.000B
Akero Therapeutics Inc. is a clinical-stage biotechnology company. It is focused on developing transformational treatments for non-alcoholic steatohepatitis and other serious metabolic disorders. The company's product pipeline consists of AKR-001, for the treatment of non-alcoholic steatohepatitis, which are in clinical stage. Akero Therapeutics Inc. is based in San Francisco, United States.
Stock Name Country Market Cap PE Ratio